Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
  • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
  • C07C209/24—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
  • C07C209/28—Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds by reduction with other reducing agents
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
  • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
  • C07C209/70—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton by reduction of unsaturated amines
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
  • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
  • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
  • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
  • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
  • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
  • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
  • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
  • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
  • C07C2602/00—Systems containing two condensed rings
  • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
  • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
  • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Definitions

• the present invention relates to a process for the chiral synthesis of enantiomeric intermediates for the biologically trans hexahydro- benzo[d]naphtho[2,1-£]azepines. These compounds have been disclosed as possessing anti-psychotic, anti-depressant and sedative activities in European Patent Application No. 230270.
• the synthesis described in European Patent Application No. 230270 produces a racemic mixture of the trans and cis amines. It has been found that the trans amine possesses higher biological activity in general than the cis amine. In addition, one enantiomer of the trans amine possesses considerably greater activity than the other. A chiral synthesis producing only a single enantiomer of the trans amine would therefore increase the yield of the biologically more active enantiomer by a factor of about two.
• R group is, for example, ethyl or isopropyi.
• R group is, for example, ethyl or isopropyi.
• the present invention relates to a process for producing compounds of the general formula 3
• n and n are independently variable and may each have a value of 0, 1 or 2, with the provisos that the sum of m and n is not greater than 3, that m may not equal zero when Q is -O- or -S-, and that when Q is -CH2-, m and n cannot both be zero;
• X is hydrogen, alkyl, hydroxy, alkoxy or trifluoromethyl;
• Y is hydrogen, hydroxy, alkoxy, -OC(0)NR2R3, -0C(0)-R9, - N(R -NHC(0)R1 or -OP(0)(OH)OR 1 ;
• Each R 1 independently is H or alkyl
• R 2 and R 3 are the same or different and each may be hydrogen (provided that both are not hydrogen), alkyl, -araikyl, cycloalkyl, aryl, hydroxyalkyl, or alkoxyalkyl; in addition, when one of R 2 and R 3 is as defined above, the other may be -R 4 NR 5 R 6 ⁇ wherein R 4 is alkanediyl, R 5 is hydrogen or alkyl and R 6 is alkyl, or R 5 and R 6 together with the nitrogen atom to which they are attached form a 1-azetidinyl, 1-pyrrolidinyl, 1-piperidinyl, 1-(4-alkylpiperazinyl), 4- morpholinyl or l-(hexahydroazepinyl) group ⁇ ; in further addition, R 2 and R 3 together with the nitrogen atom may form a 1-azetidinyl, 1-pyrrolidinyl, 1-piperidinyl, 4-morpholinyl, 1-(4
• R 9 is alkyl, araikyl, aryl, alkoxyalkyl, aryloxyalkyl, aralkoxyalkyl, cycloalkylalkyl, alkoxycarbonylalkyl, cycloalkyl, 1-adamantyl, cycloalkoxyalkyl, alkoxy, aralkyloxy, cycloalkoxy, aryloxy or -CHR 7 NHR 8 ; and
• Z is X as defined above, amino, alkylamino or -NHC(0)R 10 ⁇ wherein R 10 is hydrogen, alkyl or aryl ⁇ ;
• R11 is H or alkyl
• R1 2 is alkyl; with the proviso that R 1 ⁇ and R 12 are different;
• K is hydrogen, alkoxy, hydroxyl, arloxy, aralkyloxy, or alkyl; said process comprising: A. reducing compounds of the general formula 2
• R * which must have a chiral center due to R 1 1 and R 12 not being identical.
• R 1 " • and R 12 are chosen based on the desired absolute stereochemistry of the final product.
• said reducing agent is NaCNBH3, NaBH4, t-butyl amine borane (TBAB) or Zn dust.
• TBAB t-butyl amine borane
• the cis amine of formula 3 is converted to the trans amine of formula 4
• Another preferred embodiment of the invention further comprises producing compound 2 from a compound of formula 1
• Still another preferred embodiment of the invention comprises removing the R * group from the trans amine of formula 4 and replacing it with an H to produce a compound of the general formula 5
• halogen - represents fluoro, chloro, bromo and iodo
• alkyl - represents straight or branched carbon chains, having from 1 to 6 carbon atoms
• hydroxylalkyl - represents an alkyl group as defined above in which a hydroxy group is substituted for one of the hydrogen atoms
• haloalkyl - represents alkyl as defined above wherein one of the hydrogen atoms is replaced by a halogen as defined above
• alkylamino - represents an amino, NH2 or NH3+ group in which one or more of the hydrogens is substituted with an alkyl group as defined above
• cycloalkyl - represents a saturated carbocyclic ring having from 3 to 6 carbon atoms
• cycloalkylalkyl - represents an alkyl group as defined above in which a cycloalkyl group as defined above is substituted for one of the hydrogen atoms
• halogen - represents fluoro, chloro
• Preferred aryl groups are phenyl and 2,4-dimethylphenyl; araikyl - represents an alkyl as defined above in which an aryl group as defined above is substituted for one of the alkyl hydrogen atoms; aryloxy - represents an aryl as defined above, which is attached to a molecule by an oxygen atom (-O-aryl); aryloxyalkyl - represents an alkyl group as defined above in which an aryloxy group as defined above is substituted for one of the alkyl hydrogen atoms; aralkyloxy - represents an araikyl as defined above, which is attached to a molecule by an oxygen atom (-O-aralkyl); aralkoxyalkyl - represents an alkyl group as defined above in which an aralkyloxy group as defined above is substituted for one of the alkyl hydrogen atoms; alkoxycarbonylalkyl - represents an alkyl group as defined above in which a group
• Reaction Scheme 1 illustrates the various aspects of the process of invention.
• This invention is directed at producing compound 3.
• This intermediate then may be utilized to produce a biologically active enantiomer of hexahydrobenzo[d]naphtho[2,1-fc]azepines as the predominant reaction product without significant formation of the less active enantiomers.
• R1 , R 2 , R 3 , R 4 , R5, R6, R7 f R8, R9, RI O, R 1 1 , R 12 , Q, W, X, Y, Z, m and n are as defined above unless otherwise indicated.
• step I a compound of formula 1 , which may be obtained as disclosed in European Patent Application No. 230270, is reacted with a compound of the general formula H2NR * in a suitable solvent, preferably an organic inert solvent, e.g. toluene or benzene.
• a suitable solvent preferably an organic inert solvent, e.g. toluene or benzene.
• R * which must have a chiral center due to R 1 and R 12 not being identical.
• R 1 and R 12 are chosen- based on the desired absolute stereochemistry of the final product.
• the temperature of the reaction may be room temperature to 150° C, preferably 80-120° C, more preferably about 110° C, and the reaction is allowed to proceed to the desired completion, e.g.for from about 0.5 to 5 hours, preferably about 1.5 hours.
• step II compound 2 is reacted with a suitable reducing agent, H2 in the presence of catalyst, or a dissolving metal and acid, preferably with a reducing agent, under acidic conditions (e.g., pH 3 to 6.5, preferably pH about 5.2).
• Suitable reducing agents include NaCNBh.3, NaBH4, t-butyl amine borane and Zn dust.
• Suitable catalysts include Pd, Ni, and Rh.
• Suitable acids are any acids which provide sufficient H+ ions to attain the desired pH and to reduce the double bond. The preferred acid is acetic acid.
• the reaction takes place at any suitable temperature, e.g., from 0 to 50° C, preferably at room temperature.
• step III a compound of formula 3 (the cis amine) is epimerized to the trans amine (formula 4).
• a compound of formula 3 is reacted with a suitable strong base in a suitable solvent at any suitable temperature, e.g., 0 to 25° C, preferably about 0° C.
• the reaction proceeds to desired completion, typically in about 15 minutes to 2 hours, preferably about 30 minutes.
• Suitable strong bases include KO-t-Bu, KOH, methoxide, e.g., sodium methoxide, and NaOH, preferably KO-t-Bu and suitable solvents include polar organic solvents such as dimethylformamide (DMF) and dimethylsulfoxide (DMSO).
• suitable solvents include polar organic solvents such as dimethylformamide (DMF) and dimethylsulfoxide (DMSO).
• step IV the R * group of the transamine of formula 4 is removed catalytically using H2 gas to give a compound of formula 5.
• the reaction takes place under H2 gas at atmospheric pressure to about 100 psi, at a suitable temperature, e.g., from 0° to 100°C, preferably at 25° C.
• the reaction proceeds to desired completion, typically for a period of from 1 hour to 7 days, preferably 1 to 7 days, more preferably about 3 to 4 days in the presence of a suitable catalyst.
• Preferred catalysts include Pd and Ni.
• Step V represents the conversion of compounds of formula 5 to compounds of formula 10 as described in European Patent Application No. 230270.
• the product was dissolved in 72 mL DMF at 70°C and then added slowly to a 70°C solution of 14.4 grams sodium bicarbonate in 295 mL water. Precipitation was immediate. After stirring 15 minutes, the mixture was chilled in an ice bath with stirring, and the precipitate was collected by vacuum filtration. The wet solid was digested with 25 mL acetonitrile at 70°C for 15 minutes. After chilling, the precipitate was again collected by vacuum filtration, washed with cold ether, and dried overnight under vacuum at 85°C to give 3.15 grams of product with [ ⁇ ] D - 199.4. A second acetonitrile digestion yielded 2.62 grams of product with [ ⁇ ] D - 209.7.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=22848382

Family Applications (2)

Family Applications After (1)

Country Status (14)

Families Citing this family (4)

Family Cites Families (2)

• 1989
  • 1989-07-26 EP EP89909307A patent/EP0451145A1/en active Pending
  • 1989-07-26 AU AU40561/89A patent/AU624854B2/en not_active Ceased
  • 1989-07-26 WO PCT/US1989/003166 patent/WO1990001476A1/en not_active Ceased
  • 1989-07-26 FI FI910246A patent/FI910246A7/fi not_active Application Discontinuation
  • 1989-07-26 KR KR1019900700648A patent/KR950000699B1/ko not_active Expired - Fee Related
  • 1989-07-26 JP JP1508789A patent/JPH03505735A/ja active Pending
  • 1989-07-26 HU HU894945A patent/HUT58035A/hu unknown
  • 1989-07-27 PT PT91300A patent/PT91300B/pt not_active IP Right Cessation
  • 1989-07-27 CA CA000606860A patent/CA1325226C/en not_active Expired - Fee Related
  • 1989-07-27 EP EP89307649A patent/EP0354686A1/en not_active Ceased
  • 1989-07-27 PH PH39012A patent/PH26503A/en unknown
  • 1989-07-27 IL IL9113789A patent/IL91137A/en not_active IP Right Cessation
  • 1989-07-27 ZA ZA895733A patent/ZA895733B/xx unknown
  • 1989-07-27 NZ NZ230101A patent/NZ230101A/xx unknown
• 1991
  • 1991-01-28 NO NO910324A patent/NO175744C/no unknown

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events